Wolverine Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19	Closed	-$7.65K	–	1904
2024 Q4	$7.65K	Buy	+19	New	+$8.81K	﹤0.01%	1382
2021 Q3	–	Sell	-1,189	Closed	-$239K	–	2477
2021 Q2	$239K	Buy	1,189 +545	+85%	+$114K	﹤0.01%	1208
2021 Q1	$138K	Buy	644 +582	+939%	+$128K	﹤0.01%	1359
2020 Q4	$14K	Buy	+62	New	+$14.2K	﹤0.01%	1472
2020 Q3	–	Sell	-7	Closed	-$2K	–	1889
2020 Q2	$2K	Buy	+7	New	+$1.9K	﹤0.01%	1475
2017 Q4	–	Sell	-21,969	Closed	-$3.34M	–	1700
2017 Q3	$3.34M	Buy	21,969 +19,169	+685%	+$2.89M	0.09%	342
2017 Q2	$360K	Buy	+2,800	New	+$337K	0.01%	855
2015 Q1	–	Sell	-889	Closed	-$105K	–	2422
2014 Q4	$105K	Sell	889 -64,000	-99%	-$7.21M	﹤0.01%	1175
2014 Q3	$7.29M	Hold	64,889	–	–	0.17%	127
2014 Q2	$6.14M	Buy	64,889 +500	+0.8%	+$35.1K	0.15%	126
2014 Q1	$4.55M	Buy	64,389 +39,900	+163%	+$3.16M	0.1%	166
2013 Q4	$1.82M	Buy	+24,489	New	+$1.71M	0.04%	356
2013 Q3	–	Sell	-2,965	Closed	-$236K	–	3101
2013 Q2	$237K	Buy	+2,965	New	+$218K	0.01%	1055